- Poster presentation
- Open Access
Underreporting of methicillin-resistant Staphylococcus aureus (MRSA) carriage by surgeons in the operating room planning software
© Bandelier et al; licensee BioMed Central Ltd. 2011
- Published: 29 June 2011
- Operating Room
- Staphylococcus Aureus
- Weighted Regression
- Reporting Rate
- Planning Software
MRSA carriage should be notified to operating room (OR) teams in order to guarantee continuity of contact isolation precautions, planning of MRSA carriers after non-carriers, and adequate antibiotic prophylaxis if indicated. The objective of our study was to assess the proportion of known MRSA carriers notified in the OR software.
In our hospital, the surgeon in charge is responsible for notifying patients who carry multiresistant bacteria in the OR software at time of intervention planning. We merged the OR database with the MRSA database of our laboratory. All surgical interventions (10 surgical specialties) conducted between January and December 2010 were analyzed.
11’701 interventions were analyzed. We identified 584 (5%) interventions in known MRSA carriers. Only 318/584 (54.5%) MRSA carriers were notified as such by the surgeon in charge in the OR planning software. This reporting rate varied from 23% to 72% depending on the surgical specialties. It increased significantly with the mean weekly prevalence of MRSA carriers on each specialty ward in a weighted regression model (regression coefficient: 2.9, p=0.046).
Surgical interventions in MRSA carriers represented 5% of all interventions in our hospital. Pre-operative MRSA carriage was notified to the OR team in only 54.5% of cases, which may increase the risk of transmission and prejudice adequate antibiotic prophylaxis. Notification rates were associated with the burden of MRSA cases on the wards, which may highlight an insufficient awareness of the problem among surgeons. Beside education efforts, an automated transfer of MRSA information to the OR database should be implemented.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.